Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,433.76
+52.41
(+0.63%)
FTSE 250
20,645.38
+114.08
(+0.56%)
AIM
789.87
+6.17
(+0.79%)
GBP/EUR
1.1622
+0.0011
(+0.09%)
GBP/USD
1.2525
+0.0001
(+0.01%)
Bitcoin GBP
48,542.56
-1,650.42
(-3.29%)
MONEY
Best savings accounts that offer above inflation rates
How to earn the most interest on your savings
Oxford BioMedica plc (OXBDF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.8600
0.0000
(0.00%)
At close: 03:51PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
89,539
89,539
139,989
142,797
87,728
Cost of revenue
49,812
49,812
70,808
60,157
41,655
Gross profit
39,727
39,727
69,181
82,640
46,073
Operating expenses
Research development
59,353
59,353
60,937
40,189
29,749
Selling general and administrative
25,413
25,413
28,223
15,152
11,262
Total operating expenses
124,691
124,691
99,350
61,707
50,936
Operating income or loss
-84,964
-84,964
-30,169
20,933
-4,863
Interest expense
11,199
11,199
8,754
888
912
Income before tax
-188,527
-188,527
-45,976
19,880
-6,572
Income tax expense
-4,365
-4,365
-817
869
-327
Income from continuing operations
-184,162
-184,162
-45,159
19,011
-6,245
Net income
-157,490
-157,490
-39,157
19,011
-6,245
Net income available to common shareholders
-157,490
-157,490
-39,157
19,011
-6,245
Basic EPS
-0.64
-1.63
-0.41
0.23
-0.08
Diluted EPS
-0.64
-1.63
-0.41
0.22
-0.08
Basic average shares
96,405
96,555
94,830
83,484
79,945
Diluted average shares
96,405
96,555
94,830
85,619
79,945
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.